Results 231 to 240 of about 3,742,556 (267)
Some of the next articles are maybe not open access.

Cancer Immunotherapy

Veterinary Clinics of North America: Small Animal Practice, 2009
The immune system is generally divided into 2 primary components: the innate immune response, and the highly specific but more slowly developing adaptive or acquired immune response. Immune responses can be further separated by whether they are induced by exposure to a foreign antigen (an "active" response) or whether they are transferred through serum
openaire   +4 more sources

Vaginal Cancer

Current Treatment Options in Oncology, 2002
Carcinoma of the vagina is an uncommon gynecologic cancer in the United States and throughout the world. Carcinoma in situ of the vagina and very early stage invasive carcinoma of the vagina may be treated with surgery. However, the standard therapeutic intervention for patients with carcinoma of the vagina is radiation therapy.
openaire   +2 more sources

Vaginal Cancers

Postgraduate Obstetrics & Gynecology, 2005
Vaginal neoplasia is one of the rarest of malignancies. Intraepithelial lesions are usually first identified by an abnormal Pap smear in a woman without a cervix. Surgery or ablation of the epithelium is usually highly successful.There have not been any findings of significance since 2003 to include in this review.Invasive cancer is usually located in ...
openaire   +2 more sources

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Ca-A Cancer Journal for Clinicians, 2021
Hyuna Sung   +2 more
exaly  

Cancer statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Rebecca L Siegel   +2 more
exaly  

Cancer statistics, 2023

Ca-A Cancer Journal for Clinicians, 2023
Rebecca L Siegel   +2 more
exaly  

Cancer Statistics, 2021

Ca-A Cancer Journal for Clinicians, 2021
Rebecca L Siegel, Kimberly D Miller
exaly  

Cancer

Current Opinion in Immunology, 1996
openaire   +2 more sources

Cancer

The Spine Journal, 2019
openaire   +2 more sources

Home - About - Disclaimer - Privacy